Abstract
A 42-year-old woman with liver metastasis from adrenal cortical carcinoma was treated with mitotane (o,p′DDD) for 11 months with a minimal response. Mitotane was stopped because of severe adverse effects. Thereafter a combination of cisplatin and etoposide was given every 3 weeks. A partial response was achieved after five chemotherapy courses. Following this chemotherapy, the patient had a surgical excision of the liver metastasis and entered into a complete remission for 17 months. Etoposide plus cisplatin may be an active combination for the treatment of adrenal cortical carcinoma.
| Original language | English |
|---|---|
| Pages (from-to) | 229-231 |
| Number of pages | 3 |
| Journal | American Journal of Clinical Oncology: Cancer Clinical Trials |
| Volume | 19 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 1996 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adrenal cortical carcinoma
- Cisplatin
- Etoposide
- Mitotane
- Therapy
Fingerprint
Dive into the research topics of 'Treatment of Metastatic Adrenal Cortical Carcinoma with Etoposide (VP-16) and Cisplatin after Failure with o,p′DDD: Clinical Case Reports'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver